Technical Analysis for PTGX - Protagonist Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 20.18 -1.27% -0.26
PTGX closed down 3.49 percent on Wednesday, September 23, 2020, on 1.45 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical PTGX trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.27%
Bollinger Band Squeeze Range Contraction -1.27%
Inside Day Range Contraction -1.27%
Hammer Candlestick Bullish -4.72%
Bollinger Band Squeeze Range Contraction -4.72%
Multiple of Ten Bullish Other -4.72%
BB Squeeze + Lower Band Touch Range Contraction -4.72%
Lower Bollinger Band Touch Weakness -4.72%
Fell Below 20 DMA Bearish -4.27%
Slingshot Bullish Bullish Swing Setup -4.27%
Older End-of-Day Gignals for PTGX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% about 3 hours ago
Down 2 % about 3 hours ago
Down 1% about 3 hours ago
Up 1% about 3 hours ago
Fell Below Lower Bollinger Band about 3 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The Company's initial lead product candidates consists of PTG-100 and PTG-200, which have the potential to transform the existing treatment paradigm for inflammatory bowel disease, a GI disease consisting primarily of ulcerative colitis and Crohn's disease; PTG-300, an injectable hepcidin mimetic. Protagonist Therapeutics, Inc. is based in Milpitas, United States.
Medicine Biopharmaceutical Immunology Autoimmune Diseases Inflammatory Bowel Disease Ulcerative Colitis Abdominal Pain Crohn's Disease Colitis Hepcidin

Is PTGX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 23.25
52 Week Low 4.47
Average Volume 338,122
200-Day Moving Average 12.36
50-Day Moving Average 18.94
20-Day Moving Average 21.34
10-Day Moving Average 21.16
Average True Range 1.44
ADX 13.59
+DI 22.60
-DI 19.52
Chandelier Exit (Long, 3 ATRs ) 18.92
Chandelier Exit (Short, 3 ATRs ) 23.44
Upper Bollinger Band 22.67
Lower Bollinger Band 20.01
Percent B (%b) 0.16
BandWidth 12.49
MACD Line 0.52
MACD Signal Line 0.74
MACD Histogram -0.2185
Fundamentals Value
Market Cap 345.47 Million
Num Shares 16.9 Million
EPS -3.23
Price-to-Earnings (P/E) Ratio -6.33
Price-to-Sales 0.00
Price-to-Book 4.14
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.82
Resistance 3 (R3) 21.94 21.61 21.59
Resistance 2 (R2) 21.61 21.26 21.55 21.51
Resistance 1 (R1) 21.02 21.04 20.86 20.90 21.44
Pivot Point 20.69 20.69 20.60 20.63 20.69
Support 1 (S1) 20.10 20.34 19.94 19.98 19.44
Support 2 (S2) 19.77 20.12 19.71 19.37
Support 3 (S3) 19.18 19.77 19.29
Support 4 (S4) 19.06